TrialDiabetes, obesity & metabolism2019

Clinical pharmacology study of ipragliflozin in Japanese patients with type 1 diabetes mellitus: A phase 2, randomized, placebo-controlled trial.

Kohei Kaku et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.